Targeting Myeloid-derived Suppressor Cells (MDSCs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (PD-1)-blockade Immunotherapy against Cancers

2019-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/703531Targeting Myeloid-derived Suppressor Cells (MDSCs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (PD-1)-blockade Immunotherapy against Cancers